Center for cancer genomics (CCG) biospecimen core resource

Active Awarded Last action

Contract number
75N91022F00001
Awardee
Awarding agency
Obligated
$11,357,163

Award facts

Opportunity
  • CCGBCR2201 Solicitation number
Contract value 100% obligated
$11,357,163.00 Current and potential, with all options
Completion date 84% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Columbus, OH 43205, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Supplemental Agreement for work within scope P00008 $921,591
Other Administrative Action P00007 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI center for cancer genomics (CCG)… $1,204,730
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $0
Exercise an Option P00004 $3,465,909
Change Order P00003 $0
Exercise an Option P00002 $2,408,586
Supplemental Agreement for work within scope P00001 $0
Original award $3,356,347
Show all 11

About this award

The National Cancer Institute issued a delivery order to Research Institute At Nationwide Children's Hospital on August 25, 2022, with a ceiling value of $11.357 million for the Center for Cancer Genomics Biospecimen Core Resource, due July 31, 2027.

Work is performed in Columbus, OH under firm fixed-price terms with no set-aside. The institute serves as the biospecimen core resource supporting cancer genomics research across the National Cancer Institute's portfolio, providing specimen collection, storage, processing, and biomarker analysis capabilities.

Service Contract Inventory reporting shows the order has invoiced $3.461 million in labor costs through FY2025, with a government-paid hourly rate of $77.58/hr (FY2023) and $160.31/hr (FY2024). FY2025 reported 7.5 FTEs with no subcontractor engagement—the prime self-performed all work. Labor footprint has grown from 0.9 FTEs in FY2022 to 7.5 FTEs in FY2025, reflecting sustained demand for biospecimen services across the institute's cancer research coordinating role.

Quick answers

Who was awarded contract 75N91022F00001?

75N91022F00001 was awarded to Research Institute At Nationwide Children's Hospital by National Cancer Institute (National Institutes of Health) on August 25, 2022.

How much is contract 75N91022F00001 worth?

The government has obligated $11,357,163 on 75N91022F00001.

Is contract 75N91022F00001 an order under another contract?

Yes. 75N91022F00001 is a delivery order under HHSN261201700015I, an indefinite delivery contract.

Was contract 75N91022F00001 competed?

The extent of competition for 75N91022F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award